NCT01694901

Brief Summary

This study investigates whether general anesthesia using a Pharmacokinetic/Pharmacodynamic (PK/PD) -model-based index indicating the compound effect of different anesthetics leads to optimized outcome compared to manually controlled clinical anesthesia and computerized Electroencephalogram (EEG).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 27, 2012

Completed
1.1 years until next milestone

Study Start

First participant enrolled

November 12, 2013

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2017

Completed
Last Updated

June 28, 2019

Status Verified

June 1, 2019

Enrollment Period

2.3 years

First QC Date

September 25, 2012

Last Update Submit

June 27, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative delirium

    Nursing Delirium Csreening Scale (Nu-DESC), Confusion Assessment Method for the Intensive Care Unit (CAM-ICU), Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-R), International Classification of Diseases (ICD-10)

    In the 8-day postoperative sample period

  • Postoperative cognitive deficit

    Test Battery: Verbal Learning Test, Stroop Colour Word Test, Letter Digit Substitution Test, Concept Shifting Test

    In the 8-day postoperative sample period

Secondary Outcomes (4)

  • Wake-up time

    In the 8-day postoperative sample period

  • Duration of treatment in the recovery room

    In the 8-day postoperative sample period

  • Correlation of EEG-based depth of anesthesia (BIS®) with PK/PD-based Noxious Stimulus Response Index (NSRI) of the SmartPilot® system.

    In the 8-day postoperative sample period

  • Correlation of Bispectral index (BIS®)- and NSRI readings with Near infrared spectroscopy (NIRS) - readings as parameters of regional cerebral oxygen saturation.

    In the 8-day postoperative sample period

Study Arms (2)

SmartPilot® system

50 patients scheduled for elective surgery (general/abdominal surgery; traumatological/orthopedic surgery, gynecology, urology) in general anesthesia using the SmartPilot® system

Standard arm

50 patients scheduled for elective surgery (general/abdominal surgery; traumatological/orthopedic surgery, gynecology, urology) in general anesthesia according to the standard operating procedures of the department, i.e. manually controlled clinical anesthesia and EEG-derived parameters of anesthetic depth

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Male/female patients scheduled for elective surgery (general/abdominal surgery; traumatological/orthopedic surgery, gynecology, urology) in general anesthesia at Charité - Universitaetsmedizin Berlin, Campus Mitte and Campus Virchow-Klinikum

You may qualify if:

  • Offered patient information and written informed consent
  • Male/female patients with intended ratio of 1:1
  • patients aged greater than or equal to 60 years
  • scheduled duration of surgery longer than or equal to 60 minutes
  • elective surgery (general/abdominal surgery, traumatological/orthopedic surgery, gynecology, urology) in general anesthesia

You may not qualify if:

  • Persons without the capacity to consent
  • Unability of German language use
  • Lacking willingness to save and hand out data within the study
  • Participation in another study according to the German Medicinal Products Act within 30 days before participation in the Smart-Outcome study
  • Accommodation in an institution due to an official or judicial order
  • (Unclear) history of alcohol or substances disabuse
  • Member of staff of the Charité
  • Neurological or psychiatric disease
  • American Society of Anaesthesiologists (ASA) classification greater than or equal to class IV
  • Moribund patients
  • Due to the underlying PKPD models of the SmartPilot® system, patient with the following characteristics cannot be anesthetized using SmartPilot®:
  • Height \< 150 or \> 200 cm, respectively
  • Weight \< 40 or \> 140 kg, respectively
  • Body Mass Index \> 30
  • Age \< 18 or \> 90 years of age, respectively

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Intensive Care Medicine, Campus Virchow Klinikum, Charité - Universitätsmedizin

Berlin, 13353, Germany

Location

Study Officials

  • Spies Claudia, MD, Prof.

    Charite University, Berlin, Germany

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. C. Claudia

Study Record Dates

First Submitted

September 25, 2012

First Posted

September 27, 2012

Study Start

November 12, 2013

Primary Completion

March 1, 2016

Study Completion

July 14, 2017

Last Updated

June 28, 2019

Record last verified: 2019-06

Locations